Researcher
Lieselotte Vande Walle
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From11 May 2020 → Today - Department of Internal medicine (Department)
Member
From1 Nov 2015 → 31 Jul 2018 - Department of Biochemistry (Department)
Member
From1 Apr 2010 → 31 Oct 2015 - Department of Biomedical molecular biology (Department)
Member
From1 Oct 2002 → 17 Jan 2010
Publications
1 - 7 of 7
- Drugging the NLRP3 inflammasome : from signalling mechanisms to therapeutic targets(2024)
Authors: Lieselotte Vande Walle, Mohamed Lamkanfi
Pages: 43 - 66 - Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice(2023)
Authors: Karel Van Damme, Pieter Hertens, Arne Martens, Elisabeth Gilis, Dario Priem, Inge Bruggeman, Amelie Fossoul, Jozefien Declercq, Helena Catharine Aegerter, Andy Wullaert, et al.
- Comment on : effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3(2023)
Authors: Lieselotte Vande Walle, Mohamed Lamkanfi
Pages: E166 - E167 - Nonredundancy of IL-1 alpha and IL-1 beta is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection(2022)
Authors: Kevin Eislmayr, Annika Bestehorn, Luisa Morelli, Martina Borroni, Lieselotte Vande Walle, Mohamed Lamkanfi, Pavel Kovarik
- GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis(2022)
Authors: Dhruv Chauhan, Dieter Demon, Lieselotte Vande Walle, Oonagh Paerewijck, Annalisa Zecchin, Leslie Bosseler, Karin Santoni, Remi Planes, Sílvia Ribó Gené, Amelie Fossoul, et al.
- MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition(2019)
Authors: Lieselotte Vande Walle, Irma B Stowe, Pavel Sacha, Bettina L Lee, Dieter Demon, Amelie Fossoul, Filip Van Hauwermeiren, Pedro Henrique Viana Saavedra, Petr Simon, Vladimir Subrt, et al.
- The small GTPase Arf6 is essential for the Tram/Trif pathway in RLR4 signaling(2014)
Authors: Tim Van Acker, Lieselotte Vande Walle, Marc Goethals, Mohamed Lamkanfi, Celia Bovijn, Jan Tavernier
Pages: 1364 - 1376